Novacyt (NCYT) EUR0.0667 (CDI)

Sell:40.50pBuy:41.00p0.40p (0.97%)

Prices delayed by at least 15 minutes
Sell:40.50p
Buy:41.00p
Change:0.40p (0.97%)
Deal now
Prices delayed by at least 15 minutes
Sell:40.50p
Buy:41.00p
Change:0.40p (0.97%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Novacyt SA is a France-based company providing biotechnological solutions. The Company develops and markets solutions dedicated to the field of liquid-based cytology and molecular biology. It provides diagnostic products used in oncology, microbiology, haematology, and serology testing. The Company develops secure automated cytology named NovaPrep Processor System. It offers a solution of cytological sampling to help in the detection of precancerous and cancerous lesions. It creates bottles specifically dedicated to the optimization of cell collection. The Company’s range of products includes Bottle Gyn and No Gyn Bottle.

Key people

John Brown
Non-Executive Chairman of the Board
Lyn Dafydd Rees
Chief Executive Officer, Executive Director
Steve Gibson
Chief Financial Officer, Company Secretary, Director
Joanne Nicola Mason
Chief Scientific Officer, Executive Director
Ian Gilham
Non-Executive Director
Jean-Pierre Jacques Crinelli
Independent Non-Executive Director
Juliet Thompson
Independent Non-Executive Director
Click to see more

Key facts

  • EPIC
    ALNOV
  • Location
    France
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    FR0010397232
  • Market cap
    £28.82m
  • Employees
    240
  • Shares in issue
    70.63m
  • Exchange
    Euronext Paris
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.